Back to Journals

Clinical Epidemiology

ISSN: 1179-1349

Professor Henrik Sørensen

Professor Sørensen

Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark

Dr. Sørensen is an MD. He is a specialist in internal medicine and hepatology. Dr. Sørensen earned a PhD degree in health services research, a DMSc in clinical epidemiology, and a DSc in science (cancer and cardiovascular diseases).

From 1998 to 2006, Dr. Sørensen worked as a consultant at the Department of Gastroenterology, Hepatology, and Internal Medicine, Aarhus University Hospital. Since 2000, he has been professor of clinical epidemiology at Aarhus University, and head of Department of Clinical Epidemiology at Aarhus University Hospital. He is furthermore affiliated with Stanford University, Geisel School of Medicine at Dartmouth College, Boston University, USA, and University of North Carolina, Chapel Hill.

Dr. Sørensen has a substantial number of publications within the field of clinical epidemiology, pharmacoepidemiology, and determinants of the risk and prognosis of cardiovascular, hemostatic disorders, infections, gastrointestinal, and cancer diseases. He is principal investigator on several international studies and has been supervisor for more than 78 students who have received the PhD degree.

Dr. Sørensen is a former Chairman of the Danish Agency for Registry Research, Ministry of Science, Technology and Innovation, and currently Chair of the Committee for Strengthened Clinical and Independent Research, the Independent Research Fund Denmark. He is furthermore Member of the Anders Jahre Selection Committee, Norway.

Dr. Sørensen has been awarded with several awards including the 2012 Hagedorn Prize, the 2018 Odd Fellow Research Prize, the 2019 Erhoff Prize, the 2019 Jaap de Graeff Award from Leiden University, the Netherlands. He has also received the 2023 Marie and August Krogh Prize.

Dr Thomas Ahern

Dr Ahern

Departments of Surgery and Biochemistry, The Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, VT, USA

Thomas Ahern is an Associate Professor in the Departments of Surgery and Biochemistry at the University of Vermont’s Robert Larner, MD College of Medicine. He earned his PhD in epidemiology at the Boston University School of Public Health in 2010 and completed a post-doctoral fellowship in cancer epidemiology at the Harvard T.H. Chan School of Public Health.

Dr. Ahern's research focuses on pharmaceutical and molecular factors and their impact on breast cancer incidence and survival. Dr. Ahern also collaborates on developing quantitative methods for addressing bias in epidemiologic research. He enjoys teaching epidemiologic methods and mentoring students at all levels.

Professor Vera Ehrenstein

Professor Ehrenstein

Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark

Dr. Ehrenstein earned a doctorate in epidemiology in 2008 and a master of public health degree in epidemiology and biostatistics in 2000, from the Boston University School of Public Health. She is currently associate professor at the Department of Clinical Epidemiology, Aarhus University, Denmark; previously she held various academic positions, with roles of co-investigator or statistician for epidemiologic studies.

Dr. Ehrenstein has published peer-reviewed articles within the fields of clinical epidemiology, pharmacoepidemiology, and fetal origins of adult disease (link to publications). Dr. Ehrenstein coordinates several international post-authorization safety studies; supervises PhD students; and teaches graduate courses in clinical epidemiology, database research, and scientific publishing.

Dr Laura Horsfall

Dr Horsfall

The UCL Institute of Health Informatics, University College London, London, United Kingdom

Dr. Laura Horsfall's academic background is in Genetics (BSc), Health Services Research (MSc) and Molecular Epidemiology (PhD). She is currently a Senior Research Fellow at University College London (UCL) in the Institute of Health Informatics.

Dr. Horsfall has published in various clinical fields using different methodological approaches, including descriptive epidemiology, causal inference, prediction, and health economics. Her post-doctoral research focused on the role of serum antioxidants in cardiovascular and respiratory disease using birth cohorts, biobanks and electronic health care records. She now leads an extensive work programme linking large-scale datasets to understand how the changing environment impacts physical and mental health. Dr. Horsfall supervises post-graduate PhD/MSc students and teaches the MSc in Population Health at UCL.

Dr Erzsébet Horváth-Puhó

Dr Horváth-Puhó

Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark

Erzsébet Horváth-Puhó has a master degree in mathematics and she earned a PhD degree in health sciences in 2009. She is currently associate professor at the Department of Clinical Epidemiology, Aarhus University, Denmark.

Dr. Horváth-Puhó has published peer-reviewed articles within the fields of clinical epidemiology and pharmacoepidemiology. She has been responsible for adapting biostatistical and machine learning methods applicable in the reproductive epidemiology, research of venous thromboembolism, and neuroepidemiology. She is leader of a group of biostatisticians at the Department of Clinical Epidemiology, Aarhus University. Dr. Horváth-Puhó collaborates closely with international research institutes such as Stanford University, Boston University, London School of Hygiene Tropical Medicine, Amsterdam UMC, and Vienna Medical University.

Professor Lars Pedersen

Professor Pedersen

Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark

Lars Pedersen obtained his degree in statistics from the Department of Theoretical Statistics at Aarhus University in 1999 and earned a PhD degree from Aalborg University in 2009. He has been chief statistician at the Department of Clinical Epidemiology, Aarhus University Hospital since 2000. In 2003, he became associate professor in clinical biostatistics at Aarhus University and has been professor in clinical data science since 2012.

Dr. Pedersen has published peer-reviewed articles within the fields of clinical epidemiology and pharmacoepidemiology. He has been responsible for establishing and developing a system of high quality medical databases which are linkable by information from the Danish Civil Registration System. Dr. Pedersen is head of centre for biostatistics and data management at Department of Clinical Epidemiology. The centre employs 25 biostatisticians and data managers. Dr. Pedersen has developed and implemented epidemiologic designs and statistical methods in scientific epidemiological studies as well as in relation to monitoring quality of medical interventions in hospitals and drug safety in general. His research focuses on adverse drug effects and the prognoses of various diseases and he is the scientific manager of the department’s involvement in a number of European projects aimed at developing systems to detect adverse effects of drugs at an early stage.

In addition, Dr. Pedersen is the lead statistician on several research projects with international collaborators from Stanford University, California and University of North Carolina at Chapel Hill, North Carolina, USA.

Professor Irene Petersen

Professor Petersen

Research Department of Primary Care and Population Health, University College London, London, United Kingdom

Irene Petersen received her first MSc in Biology (by research) from Aarhus University in 1997. She received her PhD in 2002 from London University and her second MSc in Epidemiology in 2010 from London School of Hygiene and Tropical Medicine.

Dr. Petersen is Professor of Epidemiology and Health Informatics at University College London, United Kingdom. She has co-authored more than 160 publications. This includes topics such as prescribed medicine in pregnancy, physical health in people with severe mental illnesses, pharmacoepidemiology and methodological studies.

Editorial Board

Olof Akre, Adjunct Professor, Department of Molecular Medicine and Surgery, Karolinska Institute, Sweden.

Tone Bjørge, Professor, Department of Global Public Health and Primary Care, University of Bergen, Norway.

Nikolay Briko, M.D., Professor, Head of The Department of Epidemiology and Evidence Based Medicine, Sechenov First Moscow Government Medical University, Russia

M. Alan Brookhart, Ph.D., Professor, Department of Population Health Sciences, Duke University, North Carolina, USA.

Hilary Brown, PhD, MSc, Associate Professor, Department of Health & Society, University of Toronto Scarborough, and Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Pierre Duhaut, Chief of the Internal Medecine Department, RECIF (Réseau d'Epidémiologie Clinique International Francophone), Jules Verne University of Picardy, France

Reham M. ElTarabili, Assistant Professor of Microbiology, Department of Bacteriology, Immunology and Mycology, Faculty of Veterinary, Suez Canal University, Egypt.

John K Field, Professor and Director of Research, Roy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular & Integrative Biology, The University of Liverpool, UK.

Allan Hackshaw, Professor of Epidemiology & Medical Statistics, Director of Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, University College London, UK. He has extensive experience in a range of medical disciplines (including cancer treatments and diagnosis, cardiovascular disease, adult and prenatal screening, and tobacco and health). This has involved large scale observational studies, randomised trials and systematic reviews, UK.

Susan Jick, Professor of Epidemiology, Director Boston Collaborative Drug Surveillance Program, Boston University School of Public Health, Lexington, MA, USA

Helle Kieler, Head of the Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

Sinéad M Langan, Professor of Clinical Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine and Associate Director Health Data Research UK London.

Jonas F Ludvigsson, Professor of clinical epidemiology, Karolinska Institutet, Pediatrician, Örebro University Hospital, Adjunct Professor of Medicine, Columbia University, NY, USA, Scientific Secretary, Swedish Society of Medicine.



Daniel Prieto-Alhambra, Professor, Professor of Pharmaco- and Device Epidemiology, Section Head for Health Data Sciences, NDORMS, University of Oxford, UK; Professor of Real World Evidence, Department of Medical Informatics, Erasmus Medical Center University, Rotterdam, Netherlands.

Nigam H. Shah, Professor of Medicine, Stanford University, and Chief Data Scientist, Stanford Healthcare, Stanford, CA, USA.

Til Sturmer, MD, MPH, PhD, Department of Epidemiology, University of North Carolina at Chapel Hill, USA.

Gianluca Trifirò, MD, PhD, FISPE, Professor of Pharmacology - Department of Diagnostics and Public Health, University of Verona, Scientific responsible of academic spin-off “INSPIRE - Innovative Solutions For Medical Prediction And Big Data Integration In Real World Setting” Italy.

Hisashi Urushihara, Dr PH, Professor, Division of Drug Development and Regulatory Science, Faculty of Pharmacy, Keio University, President of Japanese Society of Pharmacoepidemiology, Japan.

Nick van Es, Department of Vascular Medicine, University of Amsterdam, Netherlands.

Vasiliy V. Vlassov, MD, National Research University Higher School of Economics, Vice President, Society for Evidence Based Medicine, Moscow, Russia

Noel S Weiss, Professor, Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA USA

Siyan Zhan, MD,PhD, Professor and Chair, Department of Epidemiology and Biostatistics, School of Public Health, Peking University Director, Center for Clinical Epidemiology, Peking University Third Hospital, China.